In vivo and in vitro metabolism of the synthetic cannabinoid JWH-200

2013 ◽  
Vol 27 (18) ◽  
pp. 2115-2126 ◽  
Author(s):  
Nik De Brabanter ◽  
Simone Esposito ◽  
Eva Tudela ◽  
Leen Lootens ◽  
Philip Meuleman ◽  
...  
2019 ◽  
Vol 38 (1) ◽  
pp. 160-171 ◽  
Author(s):  
Svetlana A. Appolonova ◽  
Covadonga Palacio ◽  
Ksenia M. Shestakova ◽  
Natalia V. Mesonzhnik ◽  
Alex Brito ◽  
...  

2019 ◽  
Vol 2019 (4) ◽  
Author(s):  
Stephen P.H. Alexander ◽  
Andrew J. Irving

GPR18, GPR55 and GPR119 (provisional nomenclature), although showing little structural similarity to CB1 and CB2 cannabinoid receptors, respond to endogenous agents analogous to the endogenous cannabinoid ligands, as well as some natural/synthetic cannabinoid receptor ligands [98]. Although there are multiple reports to indicate that GPR18, GPR55 and GPR119 can be activated in vitro by N-arachidonoylglycine, lysophosphatidylinositol and N-oleoylethanolamide, respectively, there is a lack of evidence for activation by these lipid messengers in vivo. As such, therefore, these receptors retain their orphan status.


2020 ◽  
Vol 187 ◽  
pp. 113349 ◽  
Author(s):  
Icaro Salgado Perovani ◽  
Daniel Blascke Carrão ◽  
Nayara Cristina Perez de Albuquerque ◽  
Anderson Rodrigo Moraes de Oliveira

1980 ◽  
Vol 52 (1) ◽  
pp. 16-21 ◽  
Author(s):  
F. Iverson ◽  
K.S. Khera ◽  
S.L. Hierlihy
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document